Ronald Silver News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ronald silver. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ronald Silver Today - Breaking & Trending Today

Analysts Set Olaplex Holdings, Inc. (NASDAQ:OLPX) Target Price at $7.66

StockNews.com lowered shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) from a strong-buy rating to a buy rating in a research note issued to investors on Thursday morning. Separately, Piper Sandler increased their target price on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research note on Tuesday, May 23rd. Ironwood Pharmaceuticals Stock Performance IRWD […] ....

United States , Jason Rickard , Piper Sandler , Renaissance Technologies , Ironwood Pharmaceuticals Inc , Ironwood Pharmaceuticals , Dimensional Fund Advisors , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals Company Profile , Ironwood Pharmaceuticals Stock Performance , Blackrock Inc , Get Rating , Ronald Silver , Street Corp , Fund Advisors , Human Therapeutics , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Stocknews Com ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Stock Rating Lowered by StockNews.com

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Thursday. Separately, Piper Sandler lifted their price objective on Ironwood Pharmaceuticals from $16.00 to $19.00 in a research report on Tuesday. Ironwood Pharmaceuticals Stock Performance Shares of NASDAQ:IRWD opened at $10.81 […] ....

United States , Piper Sandler , Thomasa Mccourt , Ironwood Pharmaceuticals Inc , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Company Profile , Miller Howard Investments Inc , Mercer Global Advisors Inc , Hillsdale Investment Management Inc , Ironwood Pharmaceuticals Stock Performance , Get Rating , Ronald Silver , State Retirement , Pension System , Global Advisors , Investment Management , Miller Howard Investments , Howard Investments , Human Therapeutics , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Stocknews Com ,

Short Interest in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Drops By 14.9%

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) saw a large decrease in short interest during the month of April. As of April 30th, there was short interest totalling 17,130,000 shares, a decrease of 14.9% from the April 15th total of 20,130,000 shares. Approximately 11.3% of the company’s stock are sold short. Based on an average […] ....

United States , Thomasa Mccourt , News Ratings For Ironwood Pharmaceuticals Daily , Millennium Management , Ironwood Pharmaceuticals Inc , Ironwood Pharmaceuticals Company Profile , Victory Capital Management Inc , Ironwood Pharmaceuticals , Norges Bank , Ironwood Pharmaceuticals Trading Down , Get Rating , Pharmaceuticals Trading Down , Ronald Silver , Capital Management , Street Corp , Two Sigma Investments , Sigma Investments , Human Therapeutics , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Rating) issued its earnings results on Thursday. The biotechnology company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.24 by $0.01, Briefing.com reports. The business had revenue of $104.06 million for the quarter, compared to analyst estimates of $100.60 million. Ironwood Pharmaceuticals had a net […] ....

United States , Thomasa Mccourt , Insider Activity At Ironwood Pharmaceuticals , Securities Exchange Commission , Ironwood Pharmaceuticals , Earnings History For Ironwood Pharmaceuticals , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals Inc , Norges Bank , Millennium Management , Ironwood Pharmaceuticals Price Performance , Get Rating , Exchange Commission , Ronald Silver , Street Corp , Sigma Investments , Two Sigma Advisers , Sigma Advisers , Human Therapeutics , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,

Ironwood Pharmaceuticals Target of Unusually High Options Trading (NASDAQ:IRWD)

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Rating) was the recipient of unusually large options trading activity on Thursday. Traders bought 4,553 call options on the stock. This is an increase of approximately 13,697% compared to the average volume of 33 call options. Insiders Place Their Bets In other Ironwood Pharmaceuticals news, COO Jason Rickard sold […] ....

United States , Jason Rickard , Ironwood Pharmaceuticals Inc , Securities Exchange Commission , Ironwood Pharmaceuticals Stock Performance , Ironwood Pharmaceuticals Company Profile , Grimes Company Inc , Ironwood Pharmaceuticals , Prospera Financial Services Inc , News Ratings For Ironwood Pharmaceuticals Daily , Hillsdale Investment Management Inc , Get Rating , Exchange Commission , Ronald Silver , State Retirement , Pension System , Financial Services Inc , Hillsdale Investment Management , Investment Management , Human Therapeutics , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,